| Technology Name | Briefcase | Lead Researcher |
|---|---|---|
Background
Emulsification in aqueous media is not effective for the encapsulation of hydrophilic drugs. Peptides and proteins may deteriorate when exposed to aqueous-organic interfaces
Neuropeptides are potent CNS neuromodulators and have many ... More | Domb Abraham | |
Additional information will be provided upon request
More | Domb Abraham | |
Additional information will be provided upon request
More | Avraham Yosefa | |
Additional information will be provided upon request
More | Domb Abraham | |
Our Innovation:
Drug-eluting stents (DES) are widely used in intravascular intervention.
The current technology is based on crystallization of drug onto stent surface (with no- polymer) Coating process is resulting in high yield coatings that ... More | Domb Abraham | |
Background
Micro-emulsions are formed more or less spontaneously when their components are brought into contact. They have been the only successful delivery systems for certain types of pharmaceutical compounds, particularly compounds such as ... More | Domb Abraham | |
Background
Emulsification in aqueous media is not effective for the encapsulation of hydrophilic drugs. Peptides and proteins may deteriorate when exposed to aqueous-organic interfaces
Neuropeptides are potent CNS neuromodulators and have many ... More | Domb Abraham | |
Company Name
Aferrix
Company Founders
Prof. Zvi Ioav Cabantchik,
Current CEO
Yael Furman, Ms.C., MBA, CEO
About the Company
Aferrix is an innovative leader in development and applications of novel tools for early diagnosis and monitoring of ... More | Cabantchik Ioav | |
Background
Many of today’s leading compounds and drugs in pipeline fail to reach clinical stages due to poor oral bioavailability. In addition, Increase in oral bioavailability leads a lower inter and intra subject variability.
Our ... More | Domb Abraham | |
Additional information will be provided upon request
More | Domb Abraham |